Startup profile · funding coverage
Tractian funding, valuation and investors
Sensors and AI software that help maintenance teams diagnose machine faults and coordinate repairs.
Keep track of Tractian
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series D
$130M · October 22, 2026
Latest known valuation
$1.4B; pre/post-money basis undisclosed
Series D · October 22, 2026
Total disclosed equity funding
$250M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
growth · Atlanta, United States
Investors in latest funding
Lead: Sapphire Ventures , M&G Catalyst
Other: N47 , General Catalyst , Bosch Ventures , 53 Stations , Monashees , Endeavor Catalyst , Norte Ventures , Y Combinator
Overview
Atlanta-based Tractian provides industrial asset-health monitoring and maintenance software for asset-heavy businesses. It announced a $130M Series D on October 22, 2026, led by Sapphire Ventures and co-led by M&G Catalyst at a $1.4B valuation; pre- or post-money basis was not disclosed. The company says more than 2,000 critical facilities use its technology, while its announcement's About section separately describes more than 2,000 customers; those measures should not be treated as interchangeable. Source: https://tractian.com/en/blog/tractian-raises-series-d-to-scale-physical-ai
Why Tractian is interesting
The company combines physical equipment data with maintenance workflows. Sapphire's investment thesis centers on proprietary failure data and expansion from one facility to multiple sites; these are investor views, not independent proof of savings.
Product & use cases
Sensors collect machine signals and software supports diagnosis and maintenance decisions. Live asset-health pricing is scoped to assets, risk and required coverage through a custom quote, rather than simply the number of sensors. Source: https://tractian.com/en/solutions/pricing
- Monitoring critical pumps, compressors and other industrial assets for developing faults.
- Supporting maintenance work orders and checking whether interventions resolve diagnosed problems.
Funding history (newest first)
Series D
2026-10-22 $130M Valuation: $1.4B; pre/post-money basis undisclosed- Sapphire Ventures (lead)
- M&G Catalyst (lead)
- N47 (participant)
- General Catalyst (participant)
- Bosch Ventures (participant)
- 53 Stations (participant)
- Monashees (participant)
- Endeavor Catalyst (participant)
- Norte Ventures (participant)
- Y Combinator (participant)
Source: Read source · tractian.com
Series C
2024-12-05 $120M- Sapphire Ventures (lead)
- General Catalyst (participant)
- Next47 (participant)
- NGP Capital (participant)
Source: Read source · tractian.com
Investors in our directory
Funds linked from Tractian's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Augury is a close machine-health and process-optimization competitor. Nanoprecise combines predictive maintenance and energy-efficiency insights. Vendor-published customer results require attribution; no independently audited savings, gross margins, typical contract value or false-alarm benchmark was verified for this profile.
-
Augury direct
Industrial machine-health and process-optimization platform; company announced a $75M Series F led by Lightrock February 19, 2025.
-
Nanoprecise direct
Energy-centered predictive maintenance; company announced $38M combined equity and debt financing March 27, 2025, without an allocation in the cited release.
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover Tractian's financing or category context.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.